Sabine Neirynck
Corporate Officer/Principal chez Intrexon ActoBiotics NV
Profil
Sabine Neirynck is currently the Director-Laboratory Operations at Intrexon ActoBiotics NV since 2009.
Previously, she worked as a Principal at Ghent University and University College Cork.
She holds a doctorate degree from Ghent University.
Postes actifs de Sabine Neirynck
| Sociétés | Poste | Début |
|---|---|---|
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Corporate Officer/Principal | 01/09/2006 |
Anciens postes connus de Sabine Neirynck
| Sociétés | Poste | Fin |
|---|---|---|
| University College Cork | Corporate Officer/Principal | - |
| Ghent University | Corporate Officer/Principal | - |
Formation de Sabine Neirynck
| Ghent University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Intrexon ActoBiotics NV
Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Health Technology |
